Skip to main content
NPJ Parkinson's Disease logoLink to NPJ Parkinson's Disease
. 2019 Jul 4;5:13. doi: 10.1038/s41531-019-0085-5

Altered dynamics of visual contextual interactions in Parkinson’s disease

M Isabel Vanegas 1,2,, Annabelle Blangero 1,3, James E Galvin 4, Alessandro Di Rocco 5, Angelo Quartarone 6, M Felice Ghilardi 7,, Simon P Kelly 1,8,
PMCID: PMC6609710  PMID: 31286057

Abstract

Over the last decades, psychophysical and electrophysiological studies in patients and animal models of Parkinson’s disease (PD), have consistently revealed a number of visual abnormalities. In particular, specific alterations of contrast sensitivity curves, electroretinogram (ERG), and visual-evoked potentials (VEP), have been attributed to dopaminergic retinal depletion. However, fundamental mechanisms of cortical visual processing, such as normalization or “gain control” computations, have not yet been examined in PD patients. Here, we measured electrophysiological indices of gain control in both space (surround suppression) and time (sensory adaptation) in PD patients based on steady-state VEP (ssVEP). Compared with controls, patients exhibited a significantly higher initial ssVEP amplitude that quickly decayed over time, and greater relative suppression of ssVEP amplitude as a function of surrounding stimulus contrast. Meanwhile, EEG frequency spectra were broadly elevated in patients relative to controls. Thus, contrary to what might be expected given the reduced contrast sensitivity often reported in PD, visual neural responses are not weaker; rather, they are initially larger but undergo an exaggerated degree of spatial and temporal gain control and are embedded within a greater background noise level. These differences may reflect cortical mechanisms that compensate for dysfunctional center-surround interactions at the retinal level.

Subject terms: Diagnostic markers, Visual system

Introduction

Parkinson’s disease (PD) is a progressive neurological disorder characterized by dopamine deficiency most famously in striatal circuits of the basal ganglia, but also in other dopamine-regulated systems, including the retina.13 The involvement of circuits other than the basal ganglia could explain some of the non-motor symptoms including sleep regulation problems, autonomic dysfunction, hyposmia, and visual abnormalities.4

Visual symptoms in PD range from blurry vision, decreased ability to discern color, loss of contrast sensitivity to circadian dysregulation, and visual hallucinations.57 Systematic abnormalities have also been reported by electrophysiological and psychophysical studies. Pattern electroretinogram (PERG) responses in patients and animal models are decreased in amplitude and increased in latency compared with controls,812 particularly in an intermediate range of spatial frequencies (2–5 cycles per degree; cpd) where contrast sensitivity is highest.9,11 Pattern visual-evoked potential (PVEP) studies have shown parallel effects,1315 including delayed latency of the N70 and P100 component in a similar range of spatial frequencies and for temporal frequencies between 4 and 5 Hz,16 and phase delay of a low-frequency steady-state response.17 Acute levodopa administration in general reversed both PERG and PVEP abnormalities, suggesting that dopamine has an important role in visual processing.1115,17 Psychophysical studies of spatiotemporal tuning curves in PD patients have confirmed a major loss of contrast sensitivity for spatial frequencies in the 2–4 cpd range and temporal frequencies between 4 and 8 Hz.1820 Given the overlap in the affected spatial and temporal frequency ranges, it is plausible that these perceptual abnormalities are linked to the retinal dysfunction reflected in the PERG, and both may arise from the dopaminergic cell degeneration that has been observed in the retina in PD.2,2123 Dopaminergic amacrine cells are present in the retinal interplexiform layer and are key players in neural transmission from photoreceptors to ganglion cells and in the generation of center-surround interactions of ganglion cell’s receptive fields, thus contributing to spatial frequency tuning.2325 Further, mouse models of retinal dopamine deficiency have shown loss of contrast sensitivity and visual acuity, resembling the visual abnormalities described in PD.26

Although those findings provide an extensive characterization of the retinally mediated visual abnormalities present in PD, relatively little is known regarding potential differences in visual processing at the early cortical level, and, to our knowledge, there has yet been no systematic study of fundamental aspects of visual processing such as spatial and temporal gain control. Here we addressed this gap by examining cortically generated, steady-state visual-evoked potentials (ssVEP) in PD and their modulation by surrounding spatial context and temporal adaptation.

We employed a recently developed paradigm designed to probe visual surround suppression whereby the perceived intensity of a stimulus decreases under the presence of a surrounding pattern,27,28 a phenomenon that relies on lateral, feedback, and feedforward connections from the earliest stages of information processing in the retina to visual cortex.29,30 As the focus of our investigation was on cortical processing, we used spatial and temporal frequencies lying outside the ranges that typically reveal retinal abnormalities in PD. We reasoned that, if the only alterations in cortex are those inherited from the retina, one should expect little or no difference in cortical responses.

We found several differences in patients with PD compared with healthy controls: (1) a greater background noise level in the frequency spectrum; (2) a higher visual response (ssVEP amplitude) that quickly adapts over time, and (3) a stronger relative suppression of the ssVEP amplitude under the presence of surrounding stimuli. These overall signatures of visual contextual interactions indicate that contrast gain control is abnormal in PD and thus may serve as biomarkers to aid diagnosis and to evaluate therapeutic efficacy.

Results

Overview

Data were analyzed from a short surround-suppression paradigm recorded as part of a larger study of 28 PD patients and 30 healthy age-matched controls. In this paradigm, subjects passively viewed a series of 2.4-s long trials in which four “foreground” grating stimuli flickered on-and-off at 25 Hz, embedded within a static (non-flickering) surround grating pattern, with both the foreground (FG) and surround (SS) contrasts varying randomly from trial to trial.

Background (no-stimulus) frequency spectrum profiles

As differences in background spectral EEG amplitude have previously been reported in PD3134 and would impact the estimation of ssVEP amplitudes driven by the external flicker stimulation, it was important first to characterize such background spectral differences. EEG spectra computed from trials with zero foreground contrast and zero surround contrast (blank screen), averaged across a cluster of six parieto-occipital electrodes where ssVEPs were measured, revealed a broadly elevated spectrum in PD relative to controls (Fig. 1). A bootstrap statistical test at the critical frequency of 25 Hz revealed a significant difference in the means (p < 0.05). Importantly, the spectral difference extended through the θ [4–7 Hz], α [8–12 Hz], and β [18–35 Hz] bands.

Fig. 1.

Fig. 1

Background frequency spectrum profiles in patients versus controls. Fast Fourier transforms were computed on the last 2240 ms of all trials with 0% foreground and 0% surround contrast (blank screen, shown in inset) and then averaged across trials and across subjects within each group. Patients showed significantly higher spectral amplitudes, marked with asterisks for each of the corresponding frequency bins (bootstrapping test, p < 0.05). Shaded error bars indicate mean ± standard error of the mean (s.e.m.)

The broad spectral elevation seen under no stimulation conditions would also have the effect of elevating the amplitude of the 25-Hz ssVEP under the flicker-stimulus conditions when measured in the same way, even if there were no underlying differences in the amplitude of the exogenous response to the flicker. To eliminate this potential confound we took two measures. First, rather than averaging the single-trial spectra, we computed Fourier spectra on the average across trials per condition, thus averaging-out the background activity levels while retaining the ssVEP signal because it is strictly phase-locked to the stimulus (Fig. 2a). Second, we further used the blank-screen condition to determine a lower number of trials to average within each control subject such that the background noise was elevated to the same average level as the PD patients. Tracing background noise levels in the 25 Hz frequency bin during the no-flicker-stimulus condition revealed that equal levels of background noise were achieved in both groups when the maximum number of available trials per condition was included for the PD group and about half of the total trials (3–4) for the controls (Fig. 2b). This random trial rejection policy was then applied in the same way in the flicker conditions.

Fig. 2.

Fig. 2

Background noise as a function of number of trials for both subject groups. a Frequency spectrum for PD and Ctrl, computed using one to the maximum amount of trials in the blank-screen (baseline) condition of 0% foreground and 0% surround contrast. b Amplitude at the 25 Hz bin as a function of number of trials. A fast Fourier transform (FFT) was computed on the average time-domain signals across the given number of trials first, with that number selected randomly 1000 times from the total trials available for that condition, and the resulting FFTs averaged. Background noise levels matched when the FFT was computed on the average signal across the maximum available trials (up to eight per subject) for PD subjects and half of the total (up to four trials per subject) for control subjects

Surround-suppression effects

Applying this noise-equalization approach, we examined ssVEP contrast response functions and temporal profiles (Figs. 3 and 4). These analyses were carried out on subsets of age-matched patients and controls without cognitive impairment (eleven per group, see methods). Contrast response functions show that ssVEP amplitude increased as a function of foreground contrast in both groups, and decreased as the contrast of the surround stimulus increased (Fig. 3a, b).

Fig. 3.

Fig. 3

Contrast response functions for three different surround contrast conditions. a Patients with Parkinson’s disease (PD). b Control subjects. A fast Fourier transform (FFT) was computed for a 2240-ms window beginning 160 ms after stimulus onset to extract the single amplitude value at the frequency of stimulation 25 Hz. Contrast response functions are constructed from the ssVEP amplitude in each stimulus configuration of foreground (FG) and surround (SS) contrasts. Foreground stimulus varied across five levels of contrast: 0, 25, 50, 75, and 100%. Surround stimulus varied across three levels of contrast: 0% contrast (black trace), 50% contrast (brown trace), and 100% contrast (yellow trace). Insets show stimulus configurations for FG 100% embedded in SS of 0 and 50% contrast. c Surround-suppression ratio. Each point corresponds to a subject. The suppression ratio is computed as the ratio between the ssVEP amplitude for FG = 100%, SS = 100% and the ssVEP amplitude for FG = 100%, SS = 0%. Error bars indicate s.e.m. d Topographical distribution of the 25 Hz steady-state visual-evoked potential amplitude as a grand average between patients and control subjects, for trials with 75 or 100% contrast foreground embedded in a midgray surround (0% contrast). The cluster of electrodes chosen to measure and statistically test ssVEP amplitude are marked with star symbols

Fig. 4.

Fig. 4

Temporal analysis. a Patients with PD. b Control subjects. The group-average ssVEP amplitude was tracked over the duration of the visual stimulation, with stimulus onset at 0 ms. We computed a short-time Fourier transform (STFT) on sliding windows of 560 ms with an overlap of 75% over the 2.4-s trial length, starting from 280 ms prior to stimulus onset. Temporal response profiles for increasing FG contrasts are plotted from left to right (0, 25, 50, 75, 100%) and each of the three surround contrasts are superimposed in each plot (black for 0%, brown for 50%, yellow for 100% contrast). The colored lines in cyan, purple, and magenta represent the model fit to the data, in which FG and divisive surround drives each exponentially decay (i.e., adapt) to varying degrees. Shaded error bars indicate mean ± s.e.m. Asterisks indicate timepoints with significantly higher amplitude of the visual response (ssVEP) in patients, reached for foreground stimulus of 75 and 100% contrast with surround contrast of 0% (p < 0.05 in bootstrapping analysis)

As in our study of younger healthy subjects,27 we computed a summary metric of the surround-suppression effect as the ratio between ssVEP amplitude corresponding to FG = 100%, SS = 100% and the ssVEP amplitude for FG = 100%, SS = 0% (Fig. 3c). Suppression ratios were 0.46 ± 0.04 for PD and 0.71 ± 0.10 (mean ± s.e.m) for control subjects, revealing a significantly stronger surround-suppression effect in PD subjects (t20 = −2.3304, p = 0.0304). Thus, ssVEP amplitude showed a greater relative reduction in patients with PD than in controls under the presence of surrounding stimuli of increasing contrasts. We found no group difference in terms of contrast response function range (t20 = 0.8; p = 0.43), computed as the difference between the ssVEP amplitude at maximum flicker contrast embedded in a midgray surround (FG = 100%, SS = 0%), and the ssVEP amplitude without either flicker or surround (FG = 0%, SS = 0%).

Temporal response profiles

Temporal profiles of the visual response were constructed by plotting ssVEP amplitude over the duration of visual stimulation (short-time Fourier transform) for each stimulus condition. We found a steep increase of the visual response in the first 500 ms after flicker onset, followed by a decay that reflected temporal adaptation. This was more evident for the high foreground contrasts. (Fig. 4a, b). The results of an analysis of variance (ANOVA) shown in Table 1 (see Methods) revealed significant differences across groups that depended on contrast levels and time.

Table 1.

Factorial ANOVA showing the main effects and interactions between group, time, foreground, and surround contrasts

F statistic p value
Group × time × foreground × surround contrast F8,13 = 2.706 p = 0.008
Group F1,20 = 3.738 p = 0.0674
Foreground F4,17 = 16.496 p = 6.7911 × 10–10
Foreground × group F4,17 = 0.606 p = 0.659
Surround contrast F2,19 = 1.660 p = 0.203
Surround contrast × group F2,19 = 4.033 p = 0.025
Time F1,20 = 21.595 p = 0.000155
Time × group F1,20 = 5.881 p = 0.025
Foreground × surround contrast F8,13 = 7.942 p = 5.5932 × 10−9
Foreground × surround contrast × group F8,13 = 1.438 p = 0.185
Foreground × time F4,17 = 31.424 p = 1.0006 × 10−15
Foreground × time × group F4,17 = 4.783 p = 0.002
Surround contrast × time F2,19 = 10.439 p = 0.000225
Surround contrast × time × group F2,19 = 1.851 p = 0.170
Foreground × surround contrast × time F8,13 = 9.421 p = 1.2695 × 10−10

To unpack this, we conducted a bootstrapping analysis testing for group differences at each timepoint and for each contrast combination. We found significant differences only for time points between 420 and 840 ms in the 75% FG, 0% SS condition, and for timepoints between 140 and 1400 ms in the 100% FG, 0% SS condition (see asterisks, Fig. 4). As the amplitude increase in PD appeared to be restricted to earlier timepoints for the un-surrounded, high contrast stimuli, we compared with post hoc test the rates of temporal decline. A Wilcoxon rank-sum test on the slope of a line fit overall timepoints from 500 to 1000 ms after stimulus onset indicated a significantly steeper, faster decay of the visual response in PD subjects (Z = −2.37; p = 0.0179).

We next examined whether these differences could be described with a model with divisive normalization reflecting surround suppression and exponential decay functions to capture temporally adapting foreground and surround drives (see Methods). Shuffle statistics applied to the group-average data fits indicated a significant difference in suppression factor (β = 1.31 in PD and 0.338 in Controls), consistent with the above findings based on the suppression ratio. However, the difference in no other model parameters reached significance, including the time constant of temporal decay (τ) and the maximum amplitude Rm, as may have been expected from the results above.

Finally, we determined whether such visual abnormalities were related to characteristics of PD. We found no significant correlations between UPDRS motor scores and maximum ssVEP amplitude (ssVEP amplitude for FG = 100%, SS = 0% in the contrast response function), or suppression ratio (Pearson r = −0.11; p = 0.759 and r = 0.32, p = 0.37, respectively). Similarly, disease duration was not significantly correlated with maximum ssVEP amplitude and suppression ratio (r = 0.32; p = 0.364, and r = 0.53, p = 0.116, respectively). Moreover, therapy did not significantly influence VEP measurements: in fact, the levels of levodopa equivalent dose did not correlate either with maximum ssVEP amplitude (r = 0.057, p = 0.875) or suppression ratio (r = 0.101; p = 0.780).

Discussion

In this study, we examined the dynamics of visual responses in PD across different foreground and surround stimulus contrasts. Our results revealed three main characteristics of the visual response in PD patients and provide a new perspective on the visual deficits reported in this disease. First, in PD there was a greater visual response than in controls for flickering stimuli presented in a no-surround configuration: the visual response in patients peaked at a significantly higher level, and rapidly decayed over time. Second, patients exhibited a marked suppression of the visual response in the presence of surrounding stimuli. The influence of stimulus context upon the ssVEP amplitude was robustly expressed on the significant decrease of ssVEP amplitude embedded in a surrounding stimulus of 100%, the maximum contrast. Third, the EEG spectrum in PD showed a significantly higher level of background activity, or noise. These three findings challenge the notion that reduced visual contrast sensitivity and visual deficits observed in PD mainly stem from retinal dysfunction.

The higher spectral power in patients over the theta, alpha and beta bands (Fig. 1) derived from occipital electrodes are in line with previous reports of increased spectral background over centroparietal regions in alpha and beta bands, mostly during dopaminergic therapy.3134

The visual response in PD reached a higher initial amplitude and more quickly decayed for visual stimuli of 75 and 100% contrast and no surround. These results are in line with those of recent animal work. For instance, in non-human primates, modulation of dopaminergic forebrain circuits with D1 receptor antagonist injected in a prefrontal cortical area enhanced the visual response magnitude and orientation selectivity.35 Moreover, a PD model in drosophila exhibited similar sensory enhancement, reflected in response gain of the contrast response function.36 While the present findings are in agreement with such an enhancement of visual responses in PD, previous human studies in PD found in some cases, decreased VEP amplitudes or, in most cases, no amplitude changes at all.8,37,38 Differences in stimulus characteristics may explain such discrepancy: stimuli were usually presented in the center of the screen, covering a screen area from at least 4–18 degrees of visual angle or full screen, at two reversals per second.8,1316 Owing to retinotopic organization, evoked responses vary dramatically with stimulus location and size and for large foveal stimuli electric fields generated in V1 tend to self-cancel owing to cortical folding.28,39 As we have found an exaggerated degree of suppression in PD, one could speculate that with much larger stimuli, the greater mutual suppression within the stimulus cancels out any increase in bottom-up stimulus drive. A more likely explanation, however, may lie in the differences in spatial frequencies used—we avoid those previously found to illuminate retinally-mediated differences. In general, our stimulation paradigm offers a view on unique aspects of visual responses; whereas in previous work transient VEP responses were evoked by sequentially presented stimuli in 200–500 ms epochs, our steady-state paradigm enables tracing response dynamics continuously over a longer stimulation interval (2.4 s), revealing a characteristic temporal profile of rise and decay.

Although both groups showed a decrease of ssVEP amplitude under the presence of surrounding stimuli, this surround-suppression effect was proportionally stronger in patients. Visual surround suppression is known to be generated by a variety of lateral, feedforward, and feedback connectivity across many hierarchical levels from retina ganglion and geniculate cells to striate and extrastriate areas.29,30 Indeed, in PD, degeneration of amacrine dopaminergic neurons might cause weakening of pre-cortical center-surround interactions in the retina. However, we found a significantly greater surround-suppression effect in the cortical responses of PD patients as well as steeper temporal adaptation. Thus, we speculate that compensatory mechanisms arising at the cortical level may account for the lack of center-surround interactions at the retinal level, and feedback from extrastriate areas to V1 may have a major role in such compensatory mechanisms,29,30,40 as is also suggested by recent imaging studies.41

In our previous work, we found a relationship between the degree of electrophysiological surround suppression and perception.27 In particular, the reduction of the point of subjective equality of a stimulus when embedded in a high contrast surround, as demonstrated earlier,42 correlates with the decrease on the ssVEP amplitude measured using our paradigm. This suggests that in patients with PD, perception of a stimulus may be excessively decreased under the presence of a surround, a prediction that will require future testing. The exaggerated spatial and temporal gain control indices, coupled with the elevated level of noise in which visual responses are embedded, may plausibly contribute to the reduced visual contrast sensitivity often observed in PD patients. However, the spatial frequency of our stimuli was outside of the range previously found to exhibit deficits in PD,18,43 and whereas contrast sensitivity effects are measured for low-contrast stimuli close to visual detection threshold, our effects were observed for much higher contrasts. Altogether, these findings highlight the need for systematic examination of a broader range of visual stimulus features and phenomena to attain a full understanding of visual system abnormalities in PD.

Electrophysiological indices of visual surround suppression may offer valuable insight into aspects of motor impairment in PD. For instance, the results of our study can explain why patients with PD and freezing of gait experience fewer freezing episodes while walking when visual cues are present on the floor.44,45 Indeed, salient stimuli help alleviate the freezing of gait episodes: one can thus speculate that the corridor resembles the “foreground” or central stimulus, embedded in “surrounding” objects, such as the doorway and walls. In PD, the pronounced surround-suppression effect is hypothetically present in a natural environment, with strong contextual interactions that “suppress” responses to central stimuli. Since only salient visual cues like the lines provide a benefit to freezing, such cues may have the potential to overcome existing suppression of context upon a central stimulus. Of course, for now this remains a speculation to be tested; our study had an insufficient number (n = 3) of patients with freezing of gait to verify whether contextual effects were stronger in this subset of patients.

This study has a few limitations. First, perceptual effects and retinal functional or structural changes46 were not assessed because of time constraints. Second, the relatively small sample of patients warrants larger studies to confirm and extend the present findings. Third, our patients were on chronic dopaminergic therapy and were tested during regular medications schedule. Although we did not find any significant relation between ssVEP amplitude or suppression ratio with either PD duration or levodopa equivalent dose, we cannot exclude that acute and chronic dopaminergic treatment as well as disease duration could play important roles in our results. Indeed, acute dopaminergic treatment can improve PERG and PVEP in PD, but mostly at intermediate spatial frequencies,14 a range that is outside the spatial and temporal frequencies we used (1 cpd and 25 Hz). To discern the role of the disease itself from the acute or chronic dopaminergic treatment, future studies should verify whether ssVEP amplitude or suppression ratio are present in just diagnosed, drug-naive patients.

Methods

Subjects

EEG data were collected on the surround-suppression paradigm as part of a larger multi-test study of 28 patients with PD (seven women) and 30 healthy control subjects (20 women), which adopted inclusive recruitment criteria that only required subjects to be right-handed and to show no signs of dementia. As described below, all subjects also received a complete neuropsychological assessment. Subjects were examined by a movement disorder neurologist using the standardized rating scales for cognitive and motor dysfunction: the Unified Parkinson Disease Rating Scale (UPDRS) and the modified Hoehn and Yahr scale. All subjects had normal or corrected-to-normal vision. All EEG recordings were conducted with patients in ON during their usual dopaminergic medication schedule, usually within one hour from their last medication.

The protocol was approved by the Institutional Review Board of The City College of New York and NYU Langone School of Medicine. All participants signed an informed consent form before the test.

In the present study, our final analysis was conducted on subjects without cognitive impairment and with sufficient trials for unbiased analysis of visual response magnitudes. Specifically, 10 controls and 10 patients were excluded because their MoCA scores were lower than 2647 and/or a diagnosis of depression; other four controls and seven patients were excluded because the number of artifact-free trials was insufficient to measure response amplitudes unconfounded by differences in background spectral EEG levels (see analysis details below). We then selected 11 control subjects from the remaining sixteen to match the two groups for age (see Tables 2 and 3), with the selection made randomly wherever multiple options for inclusion existed.

Table 2.

Description of subject groups and clinical assessment scores in the final subject pool

Patients Controls t, p
Age (years) 65.4 ± 4.5 66.7 ± 4.7 t20 = −0.69, p = 0.498
MoCA 27.6 ± 1.4 27.8 ± 1.7 t20 = −0.27, p = 0.786

All values are given as mean ± standard deviation. An independent sample t test was performed

Table 3.

Patient characteristics

Patient Gender Age Disease duration (years) Hoehn & Yahr Motor fluctuations Dystonia Freezing of gait LED Medication
1 M 60 8 2 Yes Yes Yes 100 Rasagiline
2 M 60 7 2.5 No No No 860 Sinemet Rasagiline Ropinirole
3 M 63 3 2.5 Yes No Yes 400 Levodopa
4 M 64 14 2.5 No Yes No 1130 Sinemet Ropinirole Amantadine
5 M 64 8 2 Yes Yes No 400 Sinemet Rasagiline
6 F 64 7 2.5 No No No 850 Levodopa Amantadine
7 M 65 3 2.5 Yes No No 800 Sinemet Selegiline
8 F 66 4 2 No No No 100 Rasagiline
9 M 66 4 2.5 Yes Yes No 850 Sinemet
10 M 73 3 2.5 No No No 400 Sinemet Rasagiline
11 F 74 9 3 No Yes Yes 500 Sinemet Rasagiline

The AD8 Dementia Screening Interview, the four mini physical performance test (MiniPPT) items and the Hospital Anxiety And Depression Scale (HADS) revealed no signs of clinical depression or anxiety in the final pool of subjects, without significant differences between the two groups (AD8: PD = 1.55 ± 1.63, Ctrl = 1 ± 1.61; t20 = 0.79, p = 0.44; HADS Anxiety Scale: PD = 4.27 ± 2.41, Ctrl = 3 ± 2.32; t20 = 1.26; p = 0.22; HADS Depression Scale: PD = 3.64 ± 2.01, Ctrl = 2.36 ± 2.06; t20 = 1.46; p = 0.16; MiniPPT: PD = 13 ± 1.67, Ctrl = 14.1 ± 1.3; t20 = −1.7; p = 0.103).

Experimental setup

Recordings were performed in a dark, sound-proof, radio-frequency interference-shielded room. Stimuli were presented dichoptically on a gamma-corrected CRT monitor (Dell M782) with a refresh rate of 100 Hz and 800 × 600 resolution, at a viewing distance of 57 cm. Stimulus presentation was programmed in MATLAB (The MathWorks Inc., Natick, MA), using the Psychophysics Toolbox extension.48

Surround-suppression effects were tested using steady-state visual responses to flickering foreground stimuli embedded in static surrounds, where stimuli in the upper field were flickered out-of-phase relative to those in the lower field. This method exploits anatomical and signal-summation principles to produce robust ssVEPs.28 The central “foreground” stimulus was composed of four vertically oriented circular gratings, located at an eccentricity of five degrees of visual angle, at polar angles of 20° above (two upper disks) and 45° below (two lower disks) the horizontal meridian. Disks flickered on-and-off at 25 Hz, embedded within a non-flickering full-screen static “surround” (SS) also with vertical orientation, parallel to the FG. In this configuration, the “foreground” flickering stimulus is embedded into a “surrounding” pattern in order to induce maximum visual surround-suppression effects using peripheral flickering foreground stimuli.27 In all cases, foreground and surround patterns were sinusoidally modulated luminance gratings with a spatial frequency of one cycle per degree. The average luminance of all gratings was equal to that of the midgray, 0% contrast surround, which was 65 cd/m2. Foreground contrasts could be 0% (midgray), 25%, 50%, 75%, or 100% (black and white stripes) and static surround stimulus contrast could be 0%, 50%, or 100%, both randomly assigned on each trial (see Fig. 3 insets, stimulus configurations for FG 100% embedded in SS of 0% and 50% contrast).

For each of the contrast conditions, surround stimuli were presented spatially in-phase and opposite-phase relative to the foreground, interleaved pseudorandomly, and we collapsed across spatial phase conditions within each configuration to reduce border effects (see Vanegas, et al.27). The full paradigm included a total of 120 trials (15 contrast combinations, four repetitions each for surround stimuli in and out of phase with foreground). Each trial started with the presentation of a fixation spot for 500 ms, after which the flickering foreground and static surround stimuli were simultaneously presented for 2400 ms. Subjects were instructed to maintain their fixation on the center of the screen throughout each trial.

EEG recordings

During each block, high-density electroencephalography data (Electrical Geodesics Inc., Eugene, OR) were recorded from 256 electrodes at a sample rate of 1000 Hz. We applied an online notch filter at 60 Hz. Impedances were stable below 50 kΩ. We selected 183 channels on the scalp and downsampled to 500 Hz. Eye gaze was monitored continually using an EyeLink1000 (SR-Research) eye tracker to ensure gaze was within one degree of visual angle around the fixation spot during stimulus presentation.

Data analysis

Analysis was carried out offline using in-house Matlab scripts in conjunction with topographic mapping functions of EEGLAB, an open source toolbox for EEG analysis.49 Individual epochs were extracted in the interval [−600:2600]ms relative to the visual stimulus onset at 0 ms. Blinks were detected using an in-house blink detection script based on the frontal electrodes with a threshold of 60 μV. Trial epochs were rejected if they contained a blink or an artifact > 300 μV within the 2240-ms window beginning 160 ms after stimulus onset, avoiding most of the early component of the transient visual-evoked response. We baseline-corrected each trial epoch by subtracting the mean value over the points [−50:0]ms and re-referenced all channels to average mastoids by simple subtraction. We used Fourier decomposition to examine frequency spectra and compute contrast response functions from ssVEP amplitude corresponding to increasing levels of “foreground” contrast with and without “surrounding” patterns. The paradigm was designed to elicit visual sensory responses at a high frequency (25 Hz), clear of the strongest endogenous rhythms such as alpha (10 Hz). However, spectral amplitudes at any frequency bin are influenced by differences in levels of background noise. In PD, spectral power is known to be increased compared with controls.31,33 The power increase is mainly evident over centroparietal regions in the alpha and beta ranges in levodopa-treated patients.34 We therefore began our analysis by examining the full EEG spectrum in the entire cohort of subjects by computing the fast Fourier transform (FFT) for the blank-screen (baseline) condition of FG = 0% and SS = 0% contrast (Fig. 1 inset). We computed the FFT for a 2240-ms window beginning 160 ms after each stimulus onset and then averaged across trials, and across electrodes over the central posterior midline region: Pz, POz, and Oz, and neighboring electrodes, just as in Vanegas et al.27 This analysis using the entire subject cohort confirmed the background spectral difference in PD subjects as has been previously reported in the literature (Fig. 1).31,33

This difference in background EEG noise levels could potentially confound comparisons of ssVEP amplitude between the two groups because it causes all frequencies, including the precise frequency of the ssVEP, to be elevated in PD. We thus carried out a noise-equalization procedure to preclude this confound, whereby we averaged the ssVEP measurements across fewer trials in the control subjects than in the PD patients in such a way that background spectral levels were equalized. As background brain rhythms are asynchronous to the flickering onset, the background spectrum (noise) is expected to decrease with trial number when the FFT is computed on the average across trials. To determine the trial numbers required for noise-matching, we computed the frequency spectra for the blank-screen (0% foreground and 0% surround) condition as a function of number of trials. For each number of trials, we randomly selected this number 1000 times from the available trials for this blank-screen condition and then averaged the results. We found that spectral background levels matched when the FFT was computed using the maximum trial number in PD and approximately half the available number of trials per condition in controls (Fig. 2). We consequently applied this randomized trial selection, time-domain averaging and FFT procedure to the estimation of ssVEP amplitude in all task conditions. As ssVEPs are locked to the flickering stimuli, signal averaging in the time domain reduces the background noise without affecting the amplitude of the average of the underlying oscillation. In this way, we equalized baseline noise levels across groups, so that any difference on the ssVEP was independent from the background spectral levels and not driven by differences in spectral profiles. Contrast response functions were derived by taking the number of trials for which equal levels of background spectral noise are achieved in PD and Ctrl groups.

Subjects were excluded if the minimum amount of trials per condition (7–8 for patients with PD and 4 for controls) was not met for each of the 15 contrast combinations after artifact rejection and blink detection. In the 11 PD and 11 control subjects included in the final analysis, we verified that the levels of background noise were still equalized using a t test (t20 = 0.689, p = 0.498).

Contrast response functions

In order to examine the influence of contextual surrounding patterns on the ssVEP, we derived contrast response functions as described in Vanegas, et al.27 A FFT was computed for a 2240-ms window beginning 160 ms after stimulus onset to extract the single amplitude value at the frequency of stimulation 25 Hz. To examine temporal dynamics, including the timecourse of adaptation, we computed a short-time Fourier transform (STFT) on sliding windows of 560 ms with an overlap of 75% over the 2.4-s trial length, starting from 280 ms prior to stimulus onset (Fig. 5).

Fig. 5.

Fig. 5

Methods of analysis of the visual response. Example raw EEG traces in a PD patient (red) and a Ctrl subject (black), measured from a cluster of parieto-occipital electrodes during a visual stimulation trial, FG = 100% and SS = 0% contrast. Time frequency analyses, FFT and STFT, were performed to extract the ssVEP amplitude at the frequency of stimulation 25 Hz

Model fit

As in our original study using this paradigm in young healthy subjects,27 we fitted the grand average time-resolved contrast response functions with a model accounting for variations over time as well as foreground and surround contrast. First, the basic amplitude increase as a function of foreground contrast was captured by the standard Naka-Rushton function.50 Second, the influence of the spatial surround was encapsulated in an additive term in the denominator. Third, the temporal adaptation of both the foreground and surround drives was described by decaying exponentials with the same time constant across contrasts levels and stimuli (foreground and surround) but asymptotes that were permitted to differ. The complete model is described by the relation:

rCs,Cf,t=maxRmDfnDfn+βDsn+σn,R0 1

where r is the ssVEP amplitude at time t, Rm is the maximal response, R0 is the spectral baseline noise, σ is the contrast at which half of the maximum response is achieved, β is the coefficient of suppression, which scales the influence of surround contrast in the denominator, and n is the exponent that accounts for non-linearity of the function. As in spectral EEG measurements the baseline level R0 reflects the noise floor (25-Hz amplitude even in the absence of any stimulation), we use the max function to reflect the fact that measurements cannot pass below this noise floor. The time-dependent foreground drive Df(t) and suppressive drive Ds(t) were modeled as decaying exponential functions beginning at the veridical physical contrast of the stimulus and asymptotically tending towards a fraction of that value, captured in the relations:

Dft=K,fCf+Cf1-K,fe-tτ 2
Dst=K,sCs+Cs1-K,se-tτ 3

where τ is the mutual time constant for adaptation of foreground and surround drives and Cf and Cs are the foreground and surround contrasts, respectively. K∞,f and K∞,s represent factors by which the foreground and suppressive drive are asymptotically reduced relative to the initial value. The fit was carried out on the data over the interval 420–2240 ms so that FFT windows stayed within the bounds of the stimulation period and using the method of least-squares. The best fit parameters of the model (see equations 1, 2, and 3) were as follows: PD subjects: Rm = 2.94, R0 = 0.43, n = 1.08, σ = 1, β = 1.31, τ = 1371.15, K∞,f = 0.44, K∞,s = 0.77; Ctrl subjects: Rm = 1.92, R0 = 0.46, n = 0.9, σ = 1, β = 0.34, τ = 2549.21, K∞,f = 0.49, K∞,f = 1.

Statistical analyses

To first of all test for differences in ssVEP amplitude as a function of group, time, foreground contrast, and surround contrast, and/or interactions between them, we carried out a mixed four-way ANOVA with two time points taken early (420–560 ms) and late (1540–1680 ms) in the stimulation epoch. To follow-up the interactions found in this test we assessed ssVEP amplitude differences across groups for all individual conditions using shuffle statistics with 1000 sampling iterations (random reassignment of group). Shuffling was done per time point over the duration of the visual stimulation (short-time Fourier transform), per stimulus condition. To test for spectral differences in the blank-screen condition, we performed a bootstrap analysis at each frequency bin. In this method, statistical samples were obtained by resampling from the shuffled original sample 1000 times. Surround-suppression effects and clinical scores were also tested using independent samples t tests in cases where measures met the Kolmogorov–Smirnov test for normality. When samples were not normally distributed (i.e., slope of the line, temporal response), we conducted a nonparametric Wilcoxon rank-sum test for independent groups. Correlation analyses (Pearson) were computed to test for relationships between two clinical scores (i.e., duration of the disease and motor score in the UPDRS scale, in patients) and two electrophysiological metrics: (1) ssVEP amplitude in the stimulus condition of FG = 100% and SS = 0%, and (2) surround-suppression effect or suppression ratio, calculated as the ratio between ssVEP amplitude corresponding to FG = 100%, SS=100% and the ssVEP amplitude for FG=100%, SS=0%. In order to test for significant differences between the model parameter values fit to the grand average of each group, we used shuffle statistics; specifically, we randomly reassigned group membership 500 times and fit the model to the two false “groups” each time to form a null distribution of parameter value differences across groups, and compared the true parameter value difference against this null distribution. The level of significance was set at 0.05 in all tests.

Acknowledgements

Research reported in this publication was supported by the Michael J Fox Foundation, the Safra Foundation, the National Parkinson Foundation (to MFG and ADR), the National Institutes of Health (R01 NS054864 to MFG), grants from the National Institute of General Medical Sciences (SC2-GM-099626 to SPK) and from the National Science Foundation (BCS-1358955 to SPK).

Author contributions

M.I.V., M.F.G. and S.P.K. designed the experiments. M.I.V. and A.B. conducted the experiments. M.I.V. and S.P.K. analyzed the data. M.I.V., A.B., J.G., A.D.R., A.Q., M.F.G. and S.P.K. wrote the paper.

Code availability

The scripts for analysis are available from the corresponding authors upon reasonable request.

Data availability

The data sets generated and analyzed in this study are available from the corresponding authors on reasonable request.

Competing interests

The authors declare no competing interests.

Footnotes

Publisher’s note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Contributor Information

M. Isabel Vanegas, Email: isabel.vanegas@hsc.utah.edu.

M. Felice Ghilardi, Email: lice.mg79@gmail.com.

Simon P. Kelly, Email: simon.kelly@ucd.ie

References

  • 1.Patel N, Jankovic J, Hallett M. Sensory aspects of movement disorders. Lancet Neurol. 2014;13:100–112. doi: 10.1016/S1474-4422(13)70213-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Harnois C, Dipaolo T. Decreased dopamine in the retinas of patients with Parkinson’s disease. Invest. Ophthalmol. Vis. Sci. 1990;31:2473–2475. [PubMed] [Google Scholar]
  • 3.Hadjiconstantinou M, Neff NH. Catecholamine systems of retina - a model for studying synaptic mechanisms. Life Sci. 1984;35:1135–1147. doi: 10.1016/0024-3205(84)90184-X. [DOI] [PubMed] [Google Scholar]
  • 4.Jankovic J. Parkinson’s disease: clinical features and diagnosis. J. Neurol. Neurosurg. Psychiatry. 2008;79:368–376. doi: 10.1136/jnnp.2007.131045. [DOI] [PubMed] [Google Scholar]
  • 5.Bernardin F, et al. The role of the retina in visual hallucinations: a review of the literature and implications for psychosis. Neuropsychologia. 2017;99:128–138. doi: 10.1016/j.neuropsychologia.2017.03.002. [DOI] [PubMed] [Google Scholar]
  • 6.Archibald NK, Clarke MP, Mosimann UP, Burn DJ. The retina in Parkinsons disease. Brain. 2009;132:1128–1145. doi: 10.1093/brain/awp068. [DOI] [PubMed] [Google Scholar]
  • 7.Breen DP, et al. Sleep and circadian rhythm regulation in early parkinson disease. JAMA Neurology. 2014;71:589–595. doi: 10.1001/jamaneurol.2014.65. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Nightingale S, Mitchell KW, Howe JW. Visual evoked cortical potentials and pattern electroretinograms in Parkinson’s disease and control subjects. J. Neurol. Neurosurg. Psychiatry. 1986;49:1280–1287. doi: 10.1136/jnnp.49.11.1280. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Ghilardi MF, Bodis-Wollner I, Onofrj MC, Marx MS, Glover AA. Spatial frequency-dependent abnormalities of the pattern electroretinogram and visual evoked potentials in a parkinsonian monkey model. Brain. 1988;111:131–149. doi: 10.1093/brain/111.1.131. [DOI] [PubMed] [Google Scholar]
  • 10.Ghilardi MF, Marx MS, Bodis-Wollner I, Camras CB, Glover AA. The effect of intraocular 6-Hydroxydopamine on retina processing of primates. Ann. Neurol. 1989;25:357–364. doi: 10.1002/ana.410250407. [DOI] [PubMed] [Google Scholar]
  • 11.Tagliati M, Bodis-Wollner I, Yahr MD. The pattern electroretinogram in Parkinson’s disease reveals lack of retinal spatial tuning. Electroencephalogr. Clin. Neurophysiol. 1996;100:1–11. doi: 10.1016/0168-5597(95)00169-7. [DOI] [PubMed] [Google Scholar]
  • 12.Peppe A, et al. Visual alterations in de novo Parkinson’s disease: pattern electroretinogram latencies are more delayed and more reversible by levodopa than are visual evoked potentials. Neurology. 1995;45:1144–1148. doi: 10.1212/WNL.45.6.1144. [DOI] [PubMed] [Google Scholar]
  • 13.Bodis-Wollner I, Yahr MD. Measurements of visual evoked potentials in Parkinson’s disease. Brain. 1978;101:661–671. doi: 10.1093/brain/101.4.661. [DOI] [PubMed] [Google Scholar]
  • 14.Onofrj M, Ghilardi MF, Basciani M, Gambi D. Visual evoked potentials in parkinsonism and dopamine blockade reveal a stimulus-dependent dopamine function in humans. J. Neurol. Neurosurg. Psychiatry. 1986;49:1150–1159. doi: 10.1136/jnnp.49.10.1150. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Stanzione P, et al. Pattern visual evoked potentials and electroretinogram abnormalities in Parkinson’s disease: effects of L-dopa therapy. Clinical Vision. Sciences. 1989;4:115–127. [Google Scholar]
  • 16.Marx M, et al. Temporal frequency-dependent VEP changes in Parkinson’s disease. Vis. Res. 1986;26:185–193. doi: 10.1016/0042-6989(86)90080-5. [DOI] [PubMed] [Google Scholar]
  • 17.Bodis-Wollner I, Yahr MD, Mylin L, Thornton J. Dopaminergic deficiency and delayed visual evoked potentials in humans. Ann. Neurol. 1982;11:478–483. doi: 10.1002/ana.410110507. [DOI] [PubMed] [Google Scholar]
  • 18.Bodis-Wollner I, et al. Visual dysfunction in Parkinson’s disease - loss in spatiotemporal contrast sensitivity. Brain. 1987;110:1675–1698. doi: 10.1093/brain/110.6.1675. [DOI] [PubMed] [Google Scholar]
  • 19.Bodis-Wollner I, Onofrj M. The visual system in Parkinson’s disease. Adv. Neurol. 1987;45:323–327. [PubMed] [Google Scholar]
  • 20.Regan D, Maxner C. Orientation-selective visual loss in patients with Parkinson’s disease. Brain. 1987;110:415–432. doi: 10.1093/brain/110.2.415. [DOI] [PubMed] [Google Scholar]
  • 21.Ghilardi MF, et al. Systemic 1-Methyl, 4-Phenyl, 1-2-3-6-Tetrahydropyridine (MPTP) administration decreases retinal dopamine content in primates. Life Sci. 1988;43:255–262. doi: 10.1016/0024-3205(88)90315-3. [DOI] [PubMed] [Google Scholar]
  • 22.Djamgoz MBA, Hankins MW, Hirano J, Archer SN. Neurobiology of retinal dopamine in relation to degenerative states of the tissue. Vis. Res. 1997;37:3509–3529. doi: 10.1016/S0042-6989(97)00129-6. [DOI] [PubMed] [Google Scholar]
  • 23.Witkovsky P. Dopamine and retinal function. Doc. Ophthalmol. 2004;108:17–40. doi: 10.1023/B:DOOP.0000019487.88486.0a. [DOI] [PubMed] [Google Scholar]
  • 24.Kolb H. Amacrine cells of the mammalian retina: neurocircuitry and functional roles. Eye. 1997;11:904–923. doi: 10.1038/eye.1997.230. [DOI] [PubMed] [Google Scholar]
  • 25.Frederick JM, Rayborn ME, Laties AM, Lam DMK, Hollyfield JG. Dopaminergic neurons in the human retina. J. Comp. Neurol. 1982;210:65–79. doi: 10.1002/cne.902100108. [DOI] [PubMed] [Google Scholar]
  • 26.Jackson CR, et al. Retinal dopamine mediates multiple dimensions of light-adapted vision. J. Neurosci. 2012;32:9359–9368. doi: 10.1523/JNEUROSCI.0711-12.2012. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Vanegas MI, Blangero A, Kelly SP. Electrophysiological indices of surround suppression in humans. J. Neurophysiol. 2015;113:1100–1109. doi: 10.1152/jn.00774.2014. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Vanegas, M. I., Blangero, A. & Kelly, S. P. Exploiting individual primary visual cortex geometry to boost steady state visual evoked potentials. J. Neural. Eng. 10, 036003 (2013). [DOI] [PMC free article] [PubMed]
  • 29.Nurminen, L., Merlin, S., Bijanzadeh, M., Federer, F. & Angelucci, A. Top-down feedback controls spatial summation and response amplitude in primate visual cortex. Nat. Commun.9, 2281 (2018). [DOI] [PMC free article] [PubMed]
  • 30.Angelucci A, Levitt JB, Lund JS. Anatomical origins of the classical receptive field and modulatory surround field of single neurons in macaque visual cortical area V1. Prog. Brain. Res. 2002;136:373–388. doi: 10.1016/S0079-6123(02)36031-X. [DOI] [PubMed] [Google Scholar]
  • 31.Yaar I, Shapiro MB. A quantitative study of the electroencephalographic response to levodopa treatment in parkinsonian patients. Clin. Electroencephalogr. 1983;14:82–85. doi: 10.1177/155005948301400207. [DOI] [PubMed] [Google Scholar]
  • 32.Stoffers D, et al. Slowing of oscillatory brain activity is a stable characteristic of Parkinson’s disease without dementia. Brain. 2007;130:1847–1860. doi: 10.1093/brain/awm034. [DOI] [PubMed] [Google Scholar]
  • 33.Bosboom JLW, et al. Resting state oscillatory brain dynamics in Parkinson’s disease: an MEG study. Clin. Neurophysiol. 2006;117:2521–2531. doi: 10.1016/j.clinph.2006.06.720. [DOI] [PubMed] [Google Scholar]
  • 34.Melgari, J.-M. et al. Alpha and beta EEG power reflects L-dopa acute administration in parkinsonian patients. Front. AgingNeurosci.6, 302 (2014). [DOI] [PMC free article] [PubMed]
  • 35.Noudoost B, Moore T. Control of visual cortical signals by prefrontal dopamine. Nature. 2011;474:372–375. doi: 10.1038/nature09995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Afsari F, et al. Abnormal visual gain control in a Parkinson’s disease model. Hum. Mol. Genet. 2014;23:4465–4478. doi: 10.1093/hmg/ddu159. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Kupersmith MJ, Shakin E, Siegel IM, Lieberman A. Visual system abnormalities in patients with Parkinson’s disease. Arch. Neurol. 1982;39:284–286. doi: 10.1001/archneur.1982.00510170026007. [DOI] [PubMed] [Google Scholar]
  • 38.Tartaglione A, Pizio N, Bino G, Spadavecchia L, Favale E. VEP changes in Parkinson’s disease are stimulus dependent. J. Neurol. Neurosurg. Psychiatry. 1984;47:305–307. doi: 10.1136/jnnp.47.3.305. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Gebodh N, Vanegas MI, Kelly SP. Effects of stimulus size and contrast on the initial primary visual cortical response in humaects of stimulus size and contrast on the initial primary visual cortical response in humans. Brain Topogr. 2017;30:450–460. doi: 10.1007/s10548-016-0530-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Nassi JJ, Lomber SG, Born RT. Corticocortical feedback contributes to surround suppression in V1 of the alert primate. J. Neurosci. 2013;33:8504–U8440. doi: 10.1523/JNEUROSCI.5124-12.2013. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Arrigo A, et al. Visual system involvement in patients with newly diagnosed parkinson disease. Radiology. 2017;285:885–895. doi: 10.1148/radiol.2017161732. [DOI] [PubMed] [Google Scholar]
  • 42.Chubb C, Sperling G, Solomon JA. Texture interactions determine perceived contrast. Proc. Natl. Acad. Sci. USA. 1989;86:9631–9635. doi: 10.1073/pnas.86.23.9631. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Ming W, Palidis DJ, Spering M, McKeown MJ. Visual contrast sensitivity in early-stage parkinson’s disease. Invest. Ophthalmol. Vis. Sci. 2016;57:5696–5704. doi: 10.1167/iovs.16-20025. [DOI] [PubMed] [Google Scholar]
  • 44.Beck, E. N., Martens, K. A. E. & Almeida, Q. J. Freezing of gait in Parkinson’s disease: an overload problem? PLoS ONE.10, e0144986 (2015). [DOI] [PMC free article] [PubMed]
  • 45.Donovan S, et al. Laserlight cues for gait freezing in Parkinson’s disease: an open-label study. Park. Relat. Disord. 2011;17:240–245. doi: 10.1016/j.parkreldis.2010.08.010. [DOI] [PubMed] [Google Scholar]
  • 46.Miri S, Glazman S, Mylin L, Bodis-Wollner I. A combination of retinal morphology and visual electrophysiology testing increases diagnostic yield in Parkinson’s disease. Park. Relat. Disord. 2016;22:S134–S137. doi: 10.1016/j.parkreldis.2015.09.015. [DOI] [PubMed] [Google Scholar]
  • 47.Dalrymple-Alford JC, et al. The MoCA Well-suited screen for cognitive impairment in Parkinson disease. Neurology. 2010;75:1717–1725. doi: 10.1212/WNL.0b013e3181fc29c9. [DOI] [PubMed] [Google Scholar]
  • 48.Brainard DH. The psychophysics toolbox. Spat. Vis. 1997;10:433–436. doi: 10.1163/156856897X00357. [DOI] [PubMed] [Google Scholar]
  • 49.Delorme A, Makeig S. EEGLAB: an open source toolbox for analysis of single-trial EEG dynamics including independent component analysis. J. Neurosci. Methods. 2004;134:9–21. doi: 10.1016/j.jneumeth.2003.10.009. [DOI] [PubMed] [Google Scholar]
  • 50.Naka KI, Rushton WAH. S-potentials from luminosity units in retina of fish (Cyprinidae) J. Physiol. 1966;185:587–58. doi: 10.1113/jphysiol.1966.sp008003. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Data Availability Statement

The scripts for analysis are available from the corresponding authors upon reasonable request.

The data sets generated and analyzed in this study are available from the corresponding authors on reasonable request.


Articles from NPJ Parkinson's Disease are provided here courtesy of Nature Publishing Group

RESOURCES